Your browser doesn't support javascript.
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
Le Bert, Nina; Clapham, Hannah E; Tan, Anthony T; Chia, Wan Ni; Tham, Christine Y L; Lim, Jane M; Kunasegaran, Kamini; Tan, Linda Wei Lin; Dutertre, Charles-Antoine; Shankar, Nivedita; Lim, Joey M E; Sun, Louisa Jin; Zahari, Marina; Tun, Zaw Myo; Kumar, Vishakha; Lim, Beng Lee; Lim, Siew Hoon; Chia, Adeline; Tan, Yee-Joo; Tambyah, Paul Anantharajah; Kalimuddin, Shirin; Lye, David; Low, Jenny G H; Wang, Lin-Fa; Wan, Wei Yee; Hsu, Li Yang; Bertoletti, Antonio; Tam, Clarence C.
  • Le Bert N; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Clapham HE; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Tan AT; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Chia WN; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Tham CYL; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Lim JM; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Kunasegaran K; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Tan LWL; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Dutertre CA; Inserm U1015, Gustave Roussy, Villejuif, France.
  • Shankar N; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Lim JME; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Sun LJ; Infectious Diseases, Alexandra Hospital, National University Health System, Singapore.
  • Zahari M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Tun ZM; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Kumar V; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Lim BL; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Lim SH; Department of Microbiology, Singapore General Hospital, Singapore.
  • Chia A; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Tan YJ; Infectious Diseases Translational Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Tambyah PA; Institute of Molecular and Cell Biology, A*STAR, Singapore.
  • Kalimuddin S; Infectious Disease, Department of Medicine, National University Hospital, Singapore.
  • Lye D; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Low JGH; Department of Infectious Diseases, Singapore General Hospital, Singapore.
  • Wang LF; Infectious Diseases Translational Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Wan WY; National Center of Infectious Diseases, Singapore.
  • Hsu LY; Tan Tock Seng Hospital, Singapore.
  • Bertoletti A; Lee Kong Chian School of Medicine, Singapore.
  • Tam CC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
J Exp Med ; 218(5)2021 05 03.
Article in English | MEDLINE | ID: covidwho-1109140
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features. SARS-CoV-2-specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics. We longitudinally studied SARS-CoV-2-specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion. We quantified T cells reactive to structural proteins (M, NP, and Spike) using ELISpot and cytokine secretion in whole blood. Frequencies of SARS-CoV-2-specific T cells were similar between asymptomatic and symptomatic individuals, but the former showed an increased IFN-γ and IL-2 production. This was associated with a proportional secretion of IL-10 and proinflammatory cytokines (IL-6, TNF-α, and IL-1ß) only in asymptomatic infection, while a disproportionate secretion of inflammatory cytokines was triggered by SARS-CoV-2-specific T cell activation in symptomatic individuals. Thus, asymptomatic SARS-CoV-2-infected individuals are not characterized by weak antiviral immunity; on the contrary, they mount a highly functional virus-specific cellular immune response.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphocyte Activation / T-Lymphocytes / Cytokines / Asymptomatic Infections / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Jem.20202617

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphocyte Activation / T-Lymphocytes / Cytokines / Asymptomatic Infections / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Jem.20202617